Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin

por Baranski, Zuzanna, de Jong, Yvonne, Ilkova, Trayana, Peterse, Elisabeth F.P., Cleton-Jansen, Anne-Marie, van de Water, Bob, Hogendoorn, Pancras C.W., Bovée, Judith V.M.G., Danen, Erik H.J.
Publicado 2015